03 - 04 March 2020

Program

09:00 am
Welcome

Welcome by MCIA Chair, Peter Crock
Acknowledgement of Country
Ministerial Opening

Speakers:
09:30 am
From patient to doctor: Understanding medicinal cannabis and its role in your life

This is the chance to hear from leading cancer immunobiology expert, Prof. Jonathan Cebon of the Olivia Newton-John Cancer Research Clinic. Jonathan’s experience with scientific research and patient care around novel immunotherapies and their clinical application for the treatment of melanoma, provides great insights into which of these have seen improved outcomes for cancer patients. 

He is bringing his unique perspective to the ACannabis discussion in March, giving ticket holders an exclusive understanding of his medicinal cannabis research experience and how the results may affect patients moving forward.

Speakers:
10:00 am
Morning Tea
10:45 am
An experts guide to regulations and trust in the medicinal cannabis industry

Australia's health industry can be tricky to navigate as every aspect is highly regulated, from import and export, to manufacturing and even advertising. In this session, we will have detailed discussions about industry regulations as a whole from experts in this sector, and also examine regulations and reforms in the medicinal cannabis industry. We then explore the opportunities of medicinal cannabis within the Australian and the global market and take a look at the importance and fragility of trust in this infancy period.

Speakers:

Plus facilitated panel discussion - Facilitator Nathan Davis, MedReleaf Australia

11:45 am
The Discovery Doctor: Investigating cannabinoids

Experimental therapeutics and novel treatments, drug discovery pharmacologist Dr. Scott Smid discusses the biological actions of phytocannabinoids, synthetic cannabinoids and endocannabinoids in a diverse range of areas, from gut function, inflammation and neurodegeneration.

Speakers:
12:15 pm
Lunch
01:30 pm
Stay informed: An update on clinical trials and the important research in this space

An overview of research and clinical trials taking place in the medicinal cannabis sector. This is a chance to hear from experts in the field exploring opportunities, discussing evidence-based outcomes, and sharing the challenges and road blocks that come with conducting research and clinical trials in a developing industry.

Speakers:

Followed by facilitated panel discussion - Facilitator Rhys Cohen, FreshLeaf Analytics

02:30 pm
Through the lens of the patient: Pathways and access

Through this session with National President of the Pharmacy Guild of Australia, George Tambassis, we get an unparalleled understanding of the pathways for patients seeking access to medicinal cannabis treatment in Australia. George’s influence in this industry is felt across the country and this is a unique opportunity to hear from him directly on the pathways to access. 

Speakers:
03:00 pm
Afternoon Tea
03:30 pm
Through the lens of the doctor

This session is a must for any health care practitioners to hear from a panel of leading medical professionals in the medicinal cannabis industry, as they discuss their prescribing experience during the emerging stages of the industry in Australia. They debate the challenges presented during the industry's infancy, whilst examining barriers and issues for the others to consider, before opening it up to the audience for questions.

Facilitator Daniel Minogue, Althea with panellists:

Speakers:
04:30 pm
The medicinal cannabis patient landscape – Australia and global context

Patients, products and pricing - the FreshLeaf team provides an up to date data and analysis on what's happening in Australia's medical cannabis market. ACannabis is the chance to be the first to access the Q1 2020 FreshLeaf report, with the opportunity to take a deeper dive into what the results mean with FreshLeaf Analytics Principal Consultant, Rhys Cohen.

Speakers:
05:00 pm
Close
Speakers:

Followed by Cocktail Networking Function

09:00 am
Welcome
Speakers:
09:05 am
The Australian medicinal cannabis industry in the global context

Global industry experts analyse medicinal cannabis on a worldwide scale, looking at the opportunities and challenges, where the industry is headed and evaluating its potential. In this session, we will examine Australia’s export opportunities as the industry continues to develop, and evaluate our position in the global market. This is also a unique moment to join the conversation surrounding the broader cannabis landscape overseas and what the future of this industry might look like for Australia.

Speakers:
09:45 am
The Four Corners of the Emerging Medicinal Cannabis Industry Part I

Genetic management, cultivation, agtech and our workforce. This session is an analysis and consideration of each aspect of the local medicinal cannabis industry, with experts from these fields using a technical lens to discuss research and development, and opportunities and barriers that lie within this new landscape.

Speakers:
10:35 am
Morning Tea
11:05 am
The Four Corners of the Emerging Medicinal Cannabis Industry Part II

Genetic management, cultivation, agtech and our workforce. This session is an analysis and consideration of each aspect of the local medicinal cannabis industry, with experts from these fields using a technical lens to discuss research and development, and opportunities and barriers that lie within this new landscape.

Speakers:

Facilitated panel discussion with Part I and II speakers
Facilitator - Emily Rigby, Cannatrek

11:45 am
CEO Roundtable

Roundtable with those actively involved in the cultivation and manufacture of medicinal cannabis to close with a discussion around barriers and solutions drawing together threads of the conversations in preceding sessions.

Facilitated panel discussion by Andrew Gibson, Canaccord Genuity with panel members:

Speakers:
12:45 pm
Close
Speakers:

Followed by Networking Lunch